PortfoliosLab logoPortfoliosLab logo
MRN3.L vs. 3SPY.L
Performance
Return for Risk
Dividends
Drawdowns
Volatility

Performance

MRN3.L vs. 3SPY.L - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3.L) and Leverage Shares 3x Long US 500 ETP Securities (3SPY.L). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

MRN3.L vs. 3SPY.L - Yearly Performance Comparison


2026 (YTD)2025202420232022
MRN3.L
Leverage Shares 3x Long Moderna (MRNA) ETP Securities
185.34%-93.67%-98.51%-92.76%-8.14%
3SPY.L
Leverage Shares 3x Long US 500 ETP Securities
-15.38%12.38%63.74%58.23%-41.50%

Returns By Period

In the year-to-date period, MRN3.L achieves a 185.34% return, which is significantly higher than 3SPY.L's -15.38% return.


MRN3.L

1D
5.13%
1M
-28.06%
YTD
185.34%
6M
153.22%
1Y
23.95%
3Y*
-92.58%
5Y*
10Y*

3SPY.L

1D
5.65%
1M
-12.19%
YTD
-15.38%
6M
-11.70%
1Y
21.42%
3Y*
29.62%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


MRN3.L vs. 3SPY.L - Expense Ratio Comparison

MRN3.L has a 0.75% expense ratio, which is higher than 3SPY.L's 0.01% expense ratio.


Return for Risk

MRN3.L vs. 3SPY.L — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MRN3.L
MRN3.L Risk / Return Rank: 3434
Overall Rank
MRN3.L Sharpe Ratio Rank: 1414
Sharpe Ratio Rank
MRN3.L Sortino Ratio Rank: 7070
Sortino Ratio Rank
MRN3.L Omega Ratio Rank: 5454
Omega Ratio Rank
MRN3.L Calmar Ratio Rank: 1919
Calmar Ratio Rank
MRN3.L Martin Ratio Rank: 1616
Martin Ratio Rank

3SPY.L
3SPY.L Risk / Return Rank: 2525
Overall Rank
3SPY.L Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
3SPY.L Sortino Ratio Rank: 3030
Sortino Ratio Rank
3SPY.L Omega Ratio Rank: 3939
Omega Ratio Rank
3SPY.L Calmar Ratio Rank: 2020
Calmar Ratio Rank
3SPY.L Martin Ratio Rank: 1818
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MRN3.L vs. 3SPY.L - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3.L) and Leverage Shares 3x Long US 500 ETP Securities (3SPY.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MRN3.L3SPY.LDifference

Sharpe ratio

Return per unit of total volatility

0.11

0.30

-0.19

Sortino ratio

Return per unit of downside risk

1.85

0.98

+0.87

Omega ratio

Gain probability vs. loss probability

1.21

1.17

+0.04

Calmar ratio

Return relative to maximum drawdown

0.34

0.49

-0.15

Martin ratio

Return relative to average drawdown

0.55

1.09

-0.53

MRN3.L vs. 3SPY.L - Sharpe Ratio Comparison

The current MRN3.L Sharpe Ratio is 0.11, which is lower than the 3SPY.L Sharpe Ratio of 0.30. The chart below compares the historical Sharpe Ratios of MRN3.L and 3SPY.L, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Loading graphics...

Sharpe Ratios by Period


MRN3.L3SPY.LDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.11

0.30

-0.19

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.43

0.19

-0.62

Correlation

The correlation between MRN3.L and 3SPY.L is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Dividends

MRN3.L vs. 3SPY.L - Dividend Comparison

Neither MRN3.L nor 3SPY.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

MRN3.L vs. 3SPY.L - Drawdown Comparison

The maximum MRN3.L drawdown since its inception was -100.00%, which is greater than 3SPY.L's maximum drawdown of -56.70%. Use the drawdown chart below to compare losses from any high point for MRN3.L and 3SPY.L.


Loading graphics...

Drawdown Indicators


MRN3.L3SPY.LDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-56.70%

-43.30%

Max Drawdown (1Y)

Largest decline over 1 year

-81.28%

-41.60%

-39.68%

Current Drawdown

Current decline from peak

-100.00%

-36.78%

-63.22%

Average Drawdown

Average peak-to-trough decline

-97.52%

-20.38%

-77.14%

Ulcer Index

Depth and duration of drawdowns from previous peaks

49.36%

18.78%

+30.58%

Volatility

MRN3.L vs. 3SPY.L - Volatility Comparison

Leverage Shares 3x Long Moderna (MRNA) ETP Securities (MRN3.L) has a higher volatility of 67.32% compared to Leverage Shares 3x Long US 500 ETP Securities (3SPY.L) at 12.87%. This indicates that MRN3.L's price experiences larger fluctuations and is considered to be riskier than 3SPY.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading graphics...

Volatility by Period


MRN3.L3SPY.LDifference

Volatility (1M)

Calculated over the trailing 1-month period

67.32%

12.87%

+54.45%

Volatility (6M)

Calculated over the trailing 6-month period

163.13%

48.20%

+114.93%

Volatility (1Y)

Calculated over the trailing 1-year period

213.24%

70.54%

+142.70%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

223.41%

52.52%

+170.89%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

223.41%

52.52%

+170.89%